Bayesian Capital Management’s Kindred Healthcare KND Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
Sell
-12,700
Closed -$123K 924
2017
Q4
$123K Buy
+12,700
New +$94.5K 0.03% 508
2017
Q2
Sell
-18,307
Closed -$153K 669
2017
Q1
$153K Buy
+18,307
New +$143K 0.07% 366
2016
Q4
Sell
-13,867
Closed -$142K 764
2016
Q3
$142K Buy
+13,867
New +$154K 0.09% 312
2016
Q2
Sell
-11,967
Closed -$148K 605
2016
Q1
$148K Buy
+11,967
New +$124K 0.14% 295

Other funds holding KND

Bayesian Capital Management's KND Position: Q1 2018 in Review

Bayesian Capital Management sold out of Kindred Healthcare (KND) in Q1 2018, closing a stake of 12,700 shares — an estimated $123K sold.

Bayesian Capital Management first reported a position in KND in Q1 2016 and held it in 4 quarters. The position peaked at $153K in Q1 2017. 166 funds tracked by Wall St. Rank hold KND as of Q1 2018.

  • Bayesian Capital Management reported no remaining Kindred Healthcare position as of Q1 2018 after selling out during the quarter.
  • Bayesian Capital Management sold 12,700 Kindred Healthcare shares in Q1 2018, an estimated $123K.
  • Bayesian Capital Management first reported a position in Kindred Healthcare in Q1 2016 and held it in 4 quarters.
  • Bayesian Capital Management's Kindred Healthcare position peaked at $153K in Q1 2017.
  • 166 funds tracked by Wall St. Rank held Kindred Healthcare as of Q1 2018.

Based on Bayesian Capital Management's 13F filing for Q1 2018, filed 15 May 2018.